Guardant Health CLO Exercises RSUs, Shares Withheld
Guardant Health Chief Legal Officer John G. Saia reported compensation-related stock activity tied to restricted stock units (RSUs).
Rhea-AI Filing Summary
Guardant Health Chief Legal Officer John G. Saia reported compensation-related stock activity tied to restricted stock units (RSUs). On 2026-07-01, several RSU awards vested and converted into a total of 7,063 shares of Guardant Health common stock at a stated price of $0.00 per share.
To cover tax obligations from this vesting, the company retained 3,707 shares at a price of $170.77 per share, according to the filing footnotes. These transactions reflect RSU vesting, derivative exercises, and tax withholding, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 974 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 2,925 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,497 | $0.00 | $0.00 |
| Exercise | Common Stock | 974 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,925 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,497 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,707 | $170.77 | $633K |
Footnotes (6)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
derivative security financial
non-derivative financial
restricted stock unit award financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Guardant Health (GH) report for John G. Saia?
What do the RSU footnotes in Guardant Health’s Form 4 explain?
AI-generated analysis. How Rhea-AI works. Not financial advice.